| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 5 | -30,550 | 100% | $64.6 | -$1,973,421 |
| Net | -5 | -30,550 | -100% | -$1,973,421 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Kevin T. Conroy | President and CEO, Director | $143,713,408 | 23 Dec 2025 | ||
| Sarah Condella | EVP, Human Resources | $14,333,226 | 23 Dec 2025 | ||
| Brian Baranick | EVP, GM, Precision Oncology | $11,330,204 | -$200,289 | -1.7% | 23 Dec 2025 |
| JACOB A. ORVILLE | EVP, GM, Screening | $11,083,604 | -$375,000 | -3.3% | 23 Dec 2025 |
| James Herriott | SVP, General Counsel & Sec | $7,402,999 | -$265,120 | -3.5% | 23 Dec 2025 |
| Aaron Bloomer | EVP, Chief Financial Officer | $6,700,135 | 23 Dec 2025 | ||
| Katherine S. Zanotti | Director | $3,949,335 | -$950,612 | -19% | 24 Oct 2025 |
| Everett Cunningham | Chief Commercial Officer | $3,805,686 | 30 Apr 2024 | ||
| James Edward Doyle | Director | $3,477,720 | -$182,400 | -5% | 09 Oct 2025 |
| D. SCOTT COWARD | Director | $3,316,946 | 12 Jun 2025 | ||
| DANIEL J. LEVANGIE | Director | $1,828,143 | 12 Jun 2025 | ||
| Jeffrey Thomas Elliott | Chief Financial Officer | $1,746,571 | 30 Apr 2024 | ||
| Pierre Jacquet | Director | $1,732,836 | 08 Jun 2023 | ||
| Kathleen Sebelius | Director | $1,677,656 | 13 Jun 2024 | ||
| Shacey Petrovic | Director | $1,539,738 | 12 Jun 2025 | ||
| Freda Lewis-Hall | Director | $1,447,068 | 08 Jun 2023 | ||
| Paul J. Clancy | Director | $1,387,304 | 12 Jun 2025 | ||
| Leslie Trigg | Director | $914,764 | 12 Jun 2025 | ||
| Kimberly J. Popovits | Director | $872,779 | 12 Jun 2025 | ||
| Michael J. Barber | Director | $699,886 | 12 Jun 2025 | ||
| Scannell Timothy J | Director | $418,509 | 31 Oct 2023 | ||
| Thomas D. Carey | Director | $388,962 | 02 Jun 2021 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|